Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Pathogens (Basel, Switzerland)|May 4, 2026
New Models for the Study of Ocular Toxoplasmosis. Comment on Ashander et al. Human Retinal Organoid Model of Ocular Toxoplasmosis. <i>Pathogens</i> 2025, <i>14</i>, 286Fabrizio Bruschi, Giovanni CasiniNutrients|April 17, 2019
Nutraceuticals for the Treatment of Diabetic RetinopathyMaria Grazia Rossino, Giovanni CasiniMolecular and Cellular Endocrinology|February 5, 2008
Physiology and pathology of somatostatin in the mammalian retina: a current viewDavide Cervia, Giovanni Casini, Paola BagnoliJournal of Clinical Medicine|August 4, 2019
Neuroprotective Peptides in Retinal DiseaseDavide Cervia, Elisabetta Catalani, Giovanni CasiniInvestigative Ophthalmology & Visual Science|March 28, 2006
Expression of the gamma-aminobutyric acid (GABA) plasma membrane transporter-1 in monkey and human retinaGiovanni Casini, Dennis W Rickman, Nicholas C BrechaFrontiers in Neuroscience|December 3, 2019
Relationships Between Neurodegeneration and Vascular Damage in Diabetic RetinopathyMaria Grazia Rossino, Massimo Dal Monte, Giovanni CasiniJournal of Neurochemistry|December 16, 2011
Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatinDavide Cervia, Elisabetta Catalani, Massimo Dal Monte, et al.Journal of Diabetes Research|April 29, 2016
Neuroprotection as a Therapeutic Target for Diabetic RetinopathyCristina Hernández, Massimo Dal Monte, Rafael Simó, et al.Investigative Ophthalmology & Visual Science|June 11, 2016
VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic RetinopathyRosario Amato, Martina Biagioni, Maurizio Cammalleri, et al.Progress in Retinal and Eye Research|June 17, 2014
The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseasesGiovanni Casini, Massimo Dal Monte, Irene Fornaciari, et al.Pageof 6